Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison M Schram

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Nature Reviews. Clinical Oncology|September 1, 2017
Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistanceAlison M Schram, Matthew T Chang, Philip Jonsson, et al.
Future Oncology (London, England)|September 11, 2025
PYNNACLE phase II clinical trial protocol: rezatapopt (PC14586) monotherapy in advanced or metastatic solid tumors with a <i>TP53</i> Y220C mutationAlison M Schram, Marc Fellous, Kim LeDuke, et al.
Cancer Treatment Reviews|June 2, 2026
Treatments for human epidermal growth factor receptor 2 (HER2)-altered cancers evaluated using a tumor‑agnostic approach: A narrative reviewGuilherme Harada, Jamie E Chaft, Alison M Schram, et al.
Nature Cancer|February 5, 2022
Discovery through clinical sequencing in oncologyMark T A Donoghue, Alison M Schram, David M Hyman, et al.
Cancer Cell|April 15, 2020
Toward a More Precise Future for OncologyYonina R Murciano-Goroff, Barry S Taylor, David M Hyman, et al.
Annual Review of Cancer Biology|June 28, 2024
Basket Trials: Past, Present, and FutureYonina R Murciano-Goroff, Manik Uppal, Monica Chen, et al.
Cutis|May 13, 2014
Primary cutaneous Candida tropicalis infection in a patient with B-cell lymphomaAlison M Schram, Brian Kim, Casey Carlos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2018
Learning All That We Can From MyPathwayJessica J Tao, Alison M Schram, James J Harding, et al.
Blood|January 10, 2015
Marked hyperferritinemia does not predict for HLH in the adult populationAlison M Schram, Federico Campigotto, Ann Mullally, et al.
JCO Precision Oncology|March 21, 2025
Retrospective Analysis of <i>BRCA</i>-Altered Uterine Sarcoma Treated With Poly(ADP-ribose) Polymerase InhibitorsMara Rao, Madeline Merrill, Megan Troxel, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Nature Reviews. Clinical Oncology|September 1, 2017
Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistanceAlison M Schram, Matthew T Chang, Philip Jonsson, et al.
Future Oncology (London, England)|September 11, 2025
PYNNACLE phase II clinical trial protocol: rezatapopt (PC14586) monotherapy in advanced or metastatic solid tumors with a <i>TP53</i> Y220C mutationAlison M Schram, Marc Fellous, Kim LeDuke, et al.
Cancer Treatment Reviews|June 2, 2026
Treatments for human epidermal growth factor receptor 2 (HER2)-altered cancers evaluated using a tumor‑agnostic approach: A narrative reviewGuilherme Harada, Jamie E Chaft, Alison M Schram, et al.
Nature Cancer|February 5, 2022
Discovery through clinical sequencing in oncologyMark T A Donoghue, Alison M Schram, David M Hyman, et al.
Cancer Cell|April 15, 2020
Toward a More Precise Future for OncologyYonina R Murciano-Goroff, Barry S Taylor, David M Hyman, et al.
Annual Review of Cancer Biology|June 28, 2024
Basket Trials: Past, Present, and FutureYonina R Murciano-Goroff, Manik Uppal, Monica Chen, et al.
Cutis|May 13, 2014
Primary cutaneous Candida tropicalis infection in a patient with B-cell lymphomaAlison M Schram, Brian Kim, Casey Carlos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2018
Learning All That We Can From MyPathwayJessica J Tao, Alison M Schram, James J Harding, et al.
Blood|January 10, 2015
Marked hyperferritinemia does not predict for HLH in the adult populationAlison M Schram, Federico Campigotto, Ann Mullally, et al.
JCO Precision Oncology|March 21, 2025
Retrospective Analysis of <i>BRCA</i>-Altered Uterine Sarcoma Treated With Poly(ADP-ribose) Polymerase InhibitorsMara Rao, Madeline Merrill, Megan Troxel, et al.
Pageof 8